featured
Pathologic Upgrading in Favorable Intermediate Risk Active Surveillance Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Urologic Oncology: Seminars and Original Investigations
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pathologic Upgrading in Favorable Intermediate Risk Active Surveillance Patients: Clinical Heterogeneity and Implications for Active Surveillance Decision
Urol. Oncol 2021 Mar 22;[EPub Ahead of Print], RK Sayyid, WC Reed, JZ Benton, A Lodh, P Woodruff, JH Lambert, MK Terris, CJD Wallis, Z KlaassenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.